1034
Vol. 56, No. 7
(14.0 mg).
Alkaline Hydrolysis of 2 Compound 2 (9.0 mg) was hydrolyzed under
Compound 1: Colorless needles, mp 115—117 °C (MeOH). [a]D21 ꢀ20.8° alkaline condition to give 1a {[a]D ꢁ19.7° (cꢂ0.025)} (2.7 mg) and (E)-p-
(cꢂ0.037; CHCl3). HR-EI-MS: m/z 434.2823 [M]ꢀ (Calcd for C29H38O3,
coumaric acid (3.0 mg). (E)-p-coumaric acid was identified with the authen-
434.2821). IR nmax cmꢁ1 (KBr): 3340, 2931, 1687, 1632, 1606, 1514. UV tic compound by TLC and HPLC.
lmax nm (e) (MeOH): 226 (7184), 298 (8658), 310 (8623). 1H- and 13C-
NMR spectral data, see Tables 1 and 2.
Alkaline Hydrolysis of 3 Compound 3 (15.0 mg) was dissolved in 3 ml
of 3% KOH–MeOH and refluxed for 30 min. The reaction solution was
poured into ice water and extracted with EtOAc to give a EtOAc solution.
Compound 2: Colorless amorphous solid, mp 176—178 °C (MeOH).
[a]D21 ꢁ28.2° (cꢂ0.044; CHCl3). HR-EI-MS m/z: 434.2832 [M]ꢀ (Calcd for The EtOAc solution was evaporated and purified by PLC to give 3a (10 mg).
C29H38O3, 434.2821). IR nmax cmꢁ1 (KBr): 3372, 2931, 1679, 1632, 1605, The aqueous fraction was acidified and extracted with CHCl3 to give (E)-p-
1
1516. UV lmax nm (e) (MeOH): 227 (7068), 298 (9982), 311 (10798). H- coumaric acid (3 mg). (E)-p-Coumaric acid was identified with the authentic
and 13C-NMR spectral data, see Tables 1 and 2.
sample by TLC and HPLC.
Compound 3: Colorless amorphous solid. [a]D ꢁ22.3° (cꢂ0.014,
3a: An amorphous solid. HR-EI-MS m/z: 304.2395 [M]ꢀ (Calcd for
MeOH). HR-EI-MS m/z: 450.2784 [M]ꢀ (Calcd for C29H38O4, 450.2770). IR C20H32O2, 304.2402). [a]D ꢁ13.1° (cꢂ0.034, MeOH). IR nmax cmꢁ1 (KBr):
nmax cmꢁ1 (KBr): 3384, 2928, 1694, 1606, 1515, 1167. UV lmax nm (e) 3429, 2925, 1455, 1166, 1047. UV lmax nm (e) (MeOH): 244 (8591). H-
1
(MeOH): 241 (10480), 291 (8780), 323 (8080). H- and 13C-NMR spectral NMR spectral data, see Table 1 and 13C-NMR spectral data, see Table 2.
1
data, see Tables 1 and 2.
Compound 4: Colorless amorphous solid. HR-EI-MS m/z: 450.2798 [M]ꢀ References
(Calcd for C29H38O4, 450.2770). IR nmax cmꢁ1 (KBr): 3355, 2928, 1709,
1606, 1515, 1167. UV lmax nm (e) (MeOH): 242 (10260), 293 (8350), 316
(8090). 1H- and 13C-NMR spectral data, see Tables 1 and 2.
1) Xiao D., Kuroyanagi M., Itani T., Matsuura H., Udayama M., Mu-
rakami M., Umehara K., Kawahara N., Chem. Pham. Bull., 49, 1479—
1481 (2000).
Compound 5: Colorless needles, mp 56—58 °C (MeOH), [a]D21 ꢁ94.1°
(cꢂ0.037, CHCl3). HR-EI-MS m/z: 456.3586 [M]ꢀ (Calcd for C30H46O3,
456.3603 ). IR nmax cmꢁ1 (KBr): 3454, 2930, 1703, 1650, 1470, 1385, 1255,
1090. UV lmax nm (e) (MeOH): 242 (4115). 1H- and 13C-NMR spectral
data, see Table 2.
2) Gao H., Wu L., Kuroyanagi M., Harada K., Kawahara N., Nakane T.,
Umehara K., Hirasawa A., Nakamura Y., Chem. Pham. Bull., 51,
1318—1321 (2003).
3) Kuroyanagi M., Shimomae M., Nagashima Y., Muto N., Okuda T.,
Kawahara N., Nakane T., Sano T., Chem. Pharm. Bull., 53, 1519—
1523 (2005).
4) Kuroyanagi M., Ikeda R., Gao H., Muto N., Otaki T., Sano T., Kawa-
hara N., Nakane T., Chem. Pharm. Bull., 56, 60—63 (2008).
5) Anjaneyulu A. S. R., Rao V. L., Sreedhar K., J. Nat. Prod., 65, 382—
385 (2002).
6) Delgado G., De Vivar A. R., Cardenas J., Pereda-Miranda R., Hueta
E., Phytochemistry, 23, 2285—2288 (1984).
7) Konishi T., Konoshima T., Fujiwara Y., Kiyosawa S., J. Nat. Prod., 63,
344—346 (2000).
8) Ansell S. M., Pegel K. H., Taylor D. A. H., Phytochemistry, 32, 953—
959 (1993).
9) McCrindle R., Martin A., Murray R. D. H., J. Chem. Soc. (C), 1968,
2349—2354 (1968).
10) Takeshita H., Sato T., Muroi T., Ito S., Tetrahedron Lett., 10, 3095—
3096 (1969).
Alkaline Hydrolysis of 1 Compound 1 (7.4 mg) was dissolved in 3%
KOH/MeOH (4 ml) and heated at 85 °C for 3 h. The reaction solution was
poured into ice water and extracted with EtOAc. The EtOAc solution was
evaporated and purified by PLC to give 1a (2.6 mg). The aqueous fraction
was acidified and extracted with CHCl3. The CHCl3 solution was evaporated
to give p-coumaric acid (1.5 mg). The structure of 1a was analyzed by
NMR, HR-EI-MS spectra data, and optical rotation.
Compound 1a: Colorless amorphous solid. FAB-MS; m/z 311 [MꢀNa]ꢀ
1
C20H32O, [a]D21 ꢁ23.2° (cꢂ0.026, CHCl3), H-NMR (CDCl3) dH: 0.78 (3H,
s, Me-20), 0.79 (3H, s, C-19), 0.99 (3H, s, CMe-17), 1.03 (1H, d, Jꢂ9.8 Hz,
H-14), 1.16 (1H, dd, Jꢂ11.2, 2.9 Hz, H-5), 1.44 (1H, dd, Jꢂ9.8, 2.7 Hz, H-
14), 3.11 (1H, d, Jꢂ11.0 Hz, H-18), 3.41 (1H, d, Jꢂ11.0 Hz, H-18), 5.45
(1H, d, Jꢂ5.5 Hz, H-15), 5.69 (1H, d, Jꢂ5.5 Hz). 13C-NMR (CDCl3) dC:
15.6 (C-20), 17.8 (C-19), 17.9 (C-2), 19.9 (C-6), 20.2 (C-11), 24.9 (C-17),
33.2 (C-12), 35.4 (C-3), 37.0 (C7), 37.1 (C-10), 37.5 (C-4), 38.7 (C-1), 43.6
(C-13), 48.9 (C-8), 49.0 (C-5), 52.8 (C-9), 61.2 (C-14), 72.3 (C-18), 135.2
(C-15), 136.4 (C-16).
11) Morita M., Nakanishi H., Morita H., Mihashi S., Itokawa H., Chem.
Pharm. Bull., 44, 1603—1606 (1996).